UK to get first female spy chief
Britain's foreign intelligence service, MI6, will be led by a woman for the first time in its history, UK Prime Minister Keir Starmer has announced.
Blaise Metreweli will take up the position of Chief of the Secret Intelligence Service in the fall. She is currently head of the service's technology and innovation teams, a position immortalized as 'Q' in the James Bond movies.
It was revealed in 2017 that 'Q' was a woman – but Metreweli was not named at the time.
Metreweli, a graduate of Oxford University, has previously held senior positions in both the domestic and foreign intelligence services.
Starmer described the appointment as 'historic.'
'I know Blaise will continue to provide the excellent leadership needed to defend our county and keep our people safe,' he said in a statement.
Metreweli said she was 'proud and honored' to be appointed to the role.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
Oxford University beaten to top spot in new 2026 ranking
The University of Oxford has missed out on the top spot in a new 2026 ranking. Released this week, the 2026 Complete University Guide rankings have been released which feature the prestigious institution heavily. These rankings offer a detailed look at how every UK university stacks up against key measures like student satisfaction, graduate prospects, research quality and more. The annual rankings are widely followed by students, parents and educators and include a breakdown of each set of subjects. READ MORE: David Beckham wins neighbour battle over £6m Cotswolds estate plans Cambridge claimed top spot in the new university rankings. Oxford has been beaten by bitter rival Cambridge in the overall ranking, finishing in second place. Following the Oxbridge institutions are the London School of Economics and Political Science, the University of St Andrews and Durham University. Imperial College London, Loughborough University and the University of Bath all follow in the new ranking. The University of Warwick and Lancaster University round off the top 10 while the Universities of Exeter and York rank just Mail readers can subscribe for just £4 for 4 months in this flash sale — Oxford Mail (@TheOxfordMail) June 10, 2025 Oxford has been ranked top of the Times Higher Education World University Rankings for nine consecutive years. The prestigious institution was recently named the best in the world for three subjects in international rankings. QS World University Rankings 2025 saw the prestigious institution claim the top spot for English Language and Literature, Anatomy and Physiology, and Geography. In the new 2026 Complete University Guide rankings, Oxford was ranked best in the UK in 10 subjects.
Yahoo
34 minutes ago
- Yahoo
Winter fuel payment in Scotland to match UK benefit
The Scottish Government's devolved version of the winter fuel payment will match the value of the UK benefit, John Swinney has announced. Chancellor Rachel Reeves confirmed last week that the payment would be reinstated to the majority of pensioners. Following the initial decision to cut the universal benefit, the Scottish Government was forced to delay its plans for the pension age winter heating payment, but in December it announced pensioners north of the border would receive at least £100 every year. Speaking in Glasgow on Monday, the First Minister confirmed the Scottish Government's benefit would at least match that proposed by the UK Government. Pensioners south of the border who earn under £35,000 will receive either £200 or £300. 'I'm very happy to confirm today that no pensioner in Scotland will receive less than they would under the new UK scheme,' he said. 'Details will be set out in due course by my Government, but the Scottish Government will always seek to do what is best for Scotland's pensioners.' The changes announced last week will result in further increases in funding for the Scottish Government, which the First Minister later told journalists is expected to be around £120 million. Speaking at an event on public sector reform on Monday, the First Minister hit out at the initial decision to cut the benefit. 'To be quite blunt about it, I don't believe cutting this winter lifeline was ever going to save a penny,' he said. 'Making millions of pensioners poorer makes them also colder and makes them also sicker, and that in turn puts up the bill for our social services and our NHS.' He added: 'It's one of the reasons we were so quick to step in to protect pensioners in Scotland as best as we could from that wrong decision by the UK Government. 'But now that they've seen the error of their ways, my Government will once again to the right thing by Scotland's pensioners.' The power over the payment was devolved to Social Security Scotland in time for it to be paid out last winter. When asked if he regretted not offering it to older Scots, the First Minister said: 'I might have had the power, but I didn't have the money and I can't spend money I don't have. 'If the UK Government cuts a budget, I can't spend it, and what we've done is we've taken a series of hard decisions to allow us, before the Labour Government came anywhere near doing a U-turn on this, to restore winter fuel payments to pensioners because of other hard decisions that I've made. 'So the SNP has kept faith with pensioners in Scotland when the Labour Party has deserted them.'
Yahoo
an hour ago
- Yahoo
Innovative Molecules Completes Enrollment of Phase 1b Clinical Trial of IM-250
Innovative Molecules GmbH Announces Completion of Phase 1b Enrollment for IM-250 in Genital Herpes Clinical Trial MUNICH, June 16, 2025 /PRNewswire/ -- Innovative Molecules GmbH today announced the completion of enrollment in the Phase 1b portion of its ongoing Phase 1b/2a clinical trial evaluating IM-250, a next-generation helicase-primase inhibitor targeting herpes simplex virus (HSV). This placebo-controlled study is designed to assess the safety, efficacy, and pharmacokinetics of once-weekly oral dosing of IM-250 in patients with recurrent genital herpes. The successful completion of Phase 1b enrollment marks a key inflection point in the program, supporting the continued clinical development of IM-250 and its potential to reshape a market that has seen little therapeutic innovation in over four decades. "Completing Phase 1b enrollment represents a significant milestone not only for our clinical program but also for patients who continue to face the burden of recurrent genital herpes with limited treatment options," said Dr. Anja Glaessing, Head of Medical Affairs at Innovative Molecules. Topline results from the Phase 1b portion of the study are expected in H2, 2025. About IM-250 IM-250 is a novel, orally available, selective HSV-helicase primase inhibitor. Helicase primase inhibitors block DNA unwinding in the replication fork during viral DNA-replication by a potentially uncompetitive mechanism of action. IM-250, due to its optimized molecular structure, is likely to improve target tissue penetration (neural and brain tissue), achieving adequate therapeutic exposure at the site of HSV reservoir. About Innovative Molecules Innovative Molecules GmbH is a drug development company based in Munich, Germany. With the aim to set a new treatment standard for herpes simplex induced diseases, the company is focused on the development of IM-250, a potent, second-generation helicase-primase inhibitor of HSV-1 and HSV-2. For more information visit Logo - View original content: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
